Control of autoimmune diseases by the B7-CD28 family molecules

Sudarshan Anand, Lieping Chen

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The roles of B7-CD28 family molecules in the regulation of immune responses have been intensively studied over the past decade. The findings resulting from these studies not only broaden our understanding in the control of immune responses at the molecular level, but also lead to identification of molecular targets for future manipulation and potential treatment of human diseases. There is convincing evidence that the B7-CD28 family molecules play critical roles in the control of initiation, progression and pathogenesis of autoimmune diseases, which is the focus of this review. Currently, five molecular pathways within this family have been identified and each of them appears to overlap but have distinct functions in the control of priming, activation, maturation and amplification of cellular and humoral immune responses. Rationale-based design of intervention, targeting on multiple pathways should lead to new methods and approaches for management of autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)121-128
Number of pages8
JournalCurrent Pharmaceutical Design
Volume10
Issue number2
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Autoimmune Diseases
Humoral Immunity
Cellular Immunity

Keywords

  • Autoimmunity
  • B7 family
  • Costimulation
  • Immunotherapy

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Control of autoimmune diseases by the B7-CD28 family molecules. / Anand, Sudarshan; Chen, Lieping.

In: Current Pharmaceutical Design, Vol. 10, No. 2, 2004, p. 121-128.

Research output: Contribution to journalArticle

@article{5450bb09d1274a4e80fbe9f0a00a8ae1,
title = "Control of autoimmune diseases by the B7-CD28 family molecules",
abstract = "The roles of B7-CD28 family molecules in the regulation of immune responses have been intensively studied over the past decade. The findings resulting from these studies not only broaden our understanding in the control of immune responses at the molecular level, but also lead to identification of molecular targets for future manipulation and potential treatment of human diseases. There is convincing evidence that the B7-CD28 family molecules play critical roles in the control of initiation, progression and pathogenesis of autoimmune diseases, which is the focus of this review. Currently, five molecular pathways within this family have been identified and each of them appears to overlap but have distinct functions in the control of priming, activation, maturation and amplification of cellular and humoral immune responses. Rationale-based design of intervention, targeting on multiple pathways should lead to new methods and approaches for management of autoimmune diseases.",
keywords = "Autoimmunity, B7 family, Costimulation, Immunotherapy",
author = "Sudarshan Anand and Lieping Chen",
year = "2004",
doi = "10.2174/1381612043453450",
language = "English (US)",
volume = "10",
pages = "121--128",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Control of autoimmune diseases by the B7-CD28 family molecules

AU - Anand, Sudarshan

AU - Chen, Lieping

PY - 2004

Y1 - 2004

N2 - The roles of B7-CD28 family molecules in the regulation of immune responses have been intensively studied over the past decade. The findings resulting from these studies not only broaden our understanding in the control of immune responses at the molecular level, but also lead to identification of molecular targets for future manipulation and potential treatment of human diseases. There is convincing evidence that the B7-CD28 family molecules play critical roles in the control of initiation, progression and pathogenesis of autoimmune diseases, which is the focus of this review. Currently, five molecular pathways within this family have been identified and each of them appears to overlap but have distinct functions in the control of priming, activation, maturation and amplification of cellular and humoral immune responses. Rationale-based design of intervention, targeting on multiple pathways should lead to new methods and approaches for management of autoimmune diseases.

AB - The roles of B7-CD28 family molecules in the regulation of immune responses have been intensively studied over the past decade. The findings resulting from these studies not only broaden our understanding in the control of immune responses at the molecular level, but also lead to identification of molecular targets for future manipulation and potential treatment of human diseases. There is convincing evidence that the B7-CD28 family molecules play critical roles in the control of initiation, progression and pathogenesis of autoimmune diseases, which is the focus of this review. Currently, five molecular pathways within this family have been identified and each of them appears to overlap but have distinct functions in the control of priming, activation, maturation and amplification of cellular and humoral immune responses. Rationale-based design of intervention, targeting on multiple pathways should lead to new methods and approaches for management of autoimmune diseases.

KW - Autoimmunity

KW - B7 family

KW - Costimulation

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=0346656614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346656614&partnerID=8YFLogxK

U2 - 10.2174/1381612043453450

DO - 10.2174/1381612043453450

M3 - Article

C2 - 14754392

AN - SCOPUS:0346656614

VL - 10

SP - 121

EP - 128

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 2

ER -